EBQ:ECASS III: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
(ECASS III) |
||
| Line 16: | Line 16: | ||
==Clinical Question== | ==Clinical Question== | ||
'''Is ateplase safe and effective for ischemic stroke patients when administered 3 to 4.5 hours after the onset of symptoms?''' | |||
==Conclusion== | ==Conclusion== | ||
Revision as of 06:07, 18 October 2014
incomplete Journal Club Article
Hacke W, et al. "Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke". The New England Journal of Medicine. 2008. 359(13):1317-1329.
PubMed Full text PDF
PubMed Full text PDF
Clinical Question
Is ateplase safe and effective for ischemic stroke patients when administered 3 to 4.5 hours after the onset of symptoms?
Conclusion
Major Points
Study Design
Population
Patient Demographics
Inclusion Criteria
Exclusion Criteria
Interventions
Outcomes
Primary Outcome
Secondary Outcomes
Subgroup analysis
Criticisms & Further Discussion
Funding
Sources
[[Category:Neuro]